Pertussis vaccine in adolescents and adults;La vaccination de l'adolescent et de l'adulte contre la coqueluche

Revue Medicale de Bruxelles

Volumn 25, Issue 4, 2004, Pages

  Levy J ^a   Swennen, B ^a   Van Laethem, Y ^b  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b Inst Rech Interdisc Biol Hum N

Author keywords

Acellular vaccine; Pertussis immunisation; Use in adolescents and adults

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; BACTERIAL INFECTION; BORDETELLA PERTUSSIS; CHILD; HUMAN; IMMUNIZATION; PERTUSSIS; PRACTICE GUIDELINE; REVIEW; TREATMENT INDICATION; VACCINATION;

ADOLESCENT; ADULT; HUMANS; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 5044234662     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Cody CL, Baraff LJ, Cherry JD et al: Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68: 650-60
2. Committee on Infectious Diseases of the American Academy of Pediatrics: The relationship between pertussis vaccine and brain damage: reassessment. Pediatrics 1991; 88: 397-400
3. Schmitt HJ: Acellular pertussis vaccines: the final countdown. Eur J Pediatr 1996; 155: 74-6
4. Baron S, Njamkepo E, Grimprel E et al: Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine vaccination. Pediatr Infect Dis 1998; 17: 412-8
5. Wirsing von König CH, Halperin S, Riffelmann M et al: Pertussis of adults and infants. Lancet Infect Dis 2002; 2: 744-50
6. Van der Wielen M, Van Damme P, Van Herck K: Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium). Vaccine 2003; 21: 2412-7
7. Crowcroft NS, Booy R, Harrison T et al: Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003; 88: 802-6
8. Vitek Charles R, Brian Pascual F, Baughman Andrew L et al: Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003; 22: 628-34
9. Elliott E, McIntyre P, Ridley G et al: National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J 2004; 23: 246-52
10. De Schutter I, Malfroot A, Dab I et al: Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members. Clin Infect Dis 2003; 36: 1391-6
11. Van Damme P, Burgess M: Immunogenicity of a combined diphtheria-tetanus- acellular pertussis vaccine in adults. Vaccine 2004; 22: 305-8
12. Le T, Cherry JD, Chang SJ et al: Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT study. J Infect Dis 2004; 190: 535-44. Epub 2004 Jul
13. st ESPID meeting, Taormina, Italy, 2003: abstract 259
14. Campins-Marti M, Cheng HK, Forsyth K et al: Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2002; 20: 641-6
15. Purdy KW, Hay JW, Botteman MF et al: Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Clin Infect Dis 2004; 39: 20-8. Epub 2004 jun 14